-+ 0.00%
-+ 0.00%
-+ 0.00%

Rocket Lab's Neutron Delay Has Already Been Priced In, But Has It

Barchart·11/06/2026 16:15:48
Listen to the news
Barchart +88.89% Beat Dec 2025 $-0.08 $-0.10 -25.00% Miss Mar 2026 $-0.07 $-0.06 +14.29% Beat Jun 2026 $-0.07 $-0.06 +14.29% Beat

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Rocket Lab typically reports earnings after the market close, meaning Day 0 reflects anticipation and any after-hours reaction, while Day +1 captures the first full trading session where investors digest the results and guidance.

Earnings Date Day 0 Move Day 0 Range Day +1 Move Day +1 Range
2026-08-10 -$2.79 (-3.37%) $7.06 (8.52%) -$0.03 (-0.04%) $5.94 (7.42%)
2026-05-07 -$6.07 (-7.17%) $6.86 (8.10%) +$26.89 (+34.22%) $19.75 (25.13%)
2026-02-26 +$2.45 (+3.49%) $3.93 (5.60%) -$3.55 (-4.89%) $5.49 (7.56%)
2025-11-10 +$0.26 (+0.50%) $3.74 (7.24%) -$0.66 (-1.27%) $5.75 (11.08%)
2025-08-07 +$0.11 (+0.25%) $1.48 (3.36%) +$0.48 (+1.09%) $6.42 (14.52%)
2025-05-08 +$0.81 (+3.63%) $0.95 (4.26%) -$2.59 (-11.21%) $2.67 (11.55%)
2025-02-27 -$1.42 (-6.68%) $2.41 (11.32%) +$0.66 (+3.33%) $4.32 (21.79%)
2024-11-12 -$0.12 (-0.81%) $0.78 (5.28%) +$4.17 (+28.44%) $3.90 (26.60%)
Avg Abs Move 3.24% 6.71% 10.56% 15.71%

Rocket Lab's post-earnings price behavior has been highly volatile, with Day +1 moves significantly larger than Day 0 reactions.

On average, the stock has moved 3.24% on Day 0 with a range of 6.71%, indicating relatively contained initial reactions. However, Day +1 tells a different story: the average absolute move jumps to 10.56% with a range of 15.71%, suggesting that investors often reassess their initial reactions once they've had time to digest the full earnings call and guidance.

The most dramatic example came after the May 2026 report, when the stock initially declined 7.17% on Day 0 but then surged 34.22% on Day +1—a massive reversal driven by record revenue, strong guidance, and a major launch contract announcement. Similarly, the November 2024 report saw a muted Day 0 move but a 28.44% Day +1 gain.

Conversely, the August 2026 report showed a modest 3.37% Day 0 decline followed by a flat Day +1, while the February 2026 report saw a 3.49% Day 0 gain reverse into a 4.89% Day +1 decline.

The data suggests that Rocket Lab's earnings reactions are heavily influenced by forward guidance, contract announcements, and program updates that often take time to fully digest. Investors should expect significant volatility in the session following the report, with Day +1 moves frequently exceeding 10%.

Part 2.2: Options Market Expected Move

Metric Value
Expiration Date 11/13/26 (DTE 7)
Expected Move $6.60 (12.45%)
Expected Range $46.46 to $59.66
Implied Volatility 132.40%

The options market is pricing in a 12.45% expected move for the week following earnings, which sits between the historical Day 0 average of 3.24% and the Day +1 average of 10.56%. This suggests the market is anticipating a larger-than-typical Day 0 reaction but not quite the extreme Day +1 volatility seen in past quarters. Given the Neutron delay and heightened uncertainty around execution, the options market appears to be pricing in elevated risk while acknowledging that the company's diversified revenue base may limit downside.

Part 3: What Analysts Are Saying

Analyst Consensus: Strong Buy with Significant Upside

Rocket Lab commands one of the most bullish analyst ratings in the aerospace sector. Of the 22 analysts covering the stock, 16 rate it a Strong Buy and 2 rate it a Buy, with 4 Hold ratings and zero Sells. The average recommendation of 4.55 reflects strong conviction in the company's long-term potential.

The consensus price target sits at $101.71, implying 92% upside from the current price of $53.07. Targets range from a low of $67.00 to a high of $150.00, underscoring the wide dispersion of views on how quickly Rocket Lab can execute its growth strategy. The high-end targets reflect optimism around the Iridium acquisition and Neutron's eventual success, while the low end accounts for execution risk and the delay.

Sentiment Improving Despite Recent Volatility

Analyst sentiment has improved over the past month, with one additional Strong Buy rating added. This shift comes despite the Neutron delay and recent stock weakness, suggesting that analysts view the pullback as an opportunity rather than a fundamental deterioration. The improvement reflects confidence in the Space Systems segment's momentum, the Iridium deal's strategic value, and the company's ability to grow revenue even without Neutron flying.

The consensus view is that Rocket Lab is building a differentiated, vertically integrated space platform with multiple revenue drivers. While near-term execution risk remains—particularly around Neutron and the Iridium integration—analysts see the current valuation as attractive relative to the company's long-term opportunity in launch, manufacturing, and space-based services.

Part 4: Technical Picture

Barchart Technical Opinion: 100% Sell Signal Strengthening

The Barchart Technical Opinion for Rocket Lab currently registers a 100% Sell signal, unchanged from last week but significantly stronger than the 72% Sell signal from a month ago. The signal has been consistently bearish across all three timeframes:

  • Short-term (100% Sell): Strong sell signal indicates near-term momentum is decisively negative
  • Medium-term (100% Sell): Bearish reading confirms weakness in the intermediate timeframe
  • Long-term (100% Sell): Sell signal reflects deterioration in the longer-term trend

Trend Characteristics: The signal strength is rated as Good with direction Strengthening, indicating that the bearish technical setup is becoming more pronounced heading into earnings.

Moving Average Analysis

The stock's relationship to its moving averages paints a clear picture of technical weakness. At $53.07, Rocket Lab is trading above only its 5-day moving average of $51.59. It sits below every other key moving average: the 10-day ($54.25), 20-day ($54.87), 50-day ($62.56), 100-day ($70.68), and 200-day ($78.87). This configuration—often called a "death cross" pattern when shorter averages fall below longer ones—signals sustained downward pressure.

The stock has declined 15% from its 50-day average, 25% from its 100-day, and 33% from its 200-day, reflecting the sharp selloff following the Neutron delay announcement in mid-October. The fact that the stock is only marginally above its 5-day average suggests recent attempts to stabilize have been weak.

Period Value Period Value
5-Day MA $51.59 50-Day MA $62.56
10-Day MA $54.25 100-Day MA $70.68
20-Day MA $54.87 200-Day MA $78.87

The technical setup heading into earnings is decidedly bearish, with the stock trapped below all major moving averages and momentum indicators flashing red across every timeframe. The 100% Sell signal and strengthening bearish trend suggest that any disappointment on earnings, guidance, or Neutron timelines could trigger further downside. However, the stock's 33% decline from its 200-day average also means much of the bad news may already be priced in. A strong Q3 revenue print, solid backlog conversion, and concrete Neutron milestones could provide the catalyst needed to reverse the technical damage. Key resistance now sits at the 50-day moving average of $62.56, while support appears limited until the recent lows near $46.

This article was generated using Barchart’s automated content technology and existing data APIs. As a result, we are able to provide readers with timely, actionable, in-depth analysis on more equities, allowing them to make more informed decisions. All information and data in this article is solely for informational purposes. For more information, please view the Barchart Disclosure Policy here. And, if you would like to report any inaccuracies, please contact news@barchart.com.